Are Payers Ganging up on Clinical Laboratories and Pathology Groups? Is this a Trend or Simply a Sign of Tougher Financial Times?

Medical laboratories today struggle to submit clean claims and be promptly and adequately reimbursed as health insurers institute burdensome requirements and audit more labs Across the nation, clinical laboratories and anatomic pathology groups of all sizes struggle to get payment for lab test claims. Veteran lab executives say they cannot remember any time in the past when medical laboratories were challenged on the front-end with getting lab test claims paid while also dealing on the...

California’s John Muir Health Closes Core Lab, Sells Its Clinical Laboratory Outreach and Reference Business to LabCorp

Laboratory Corporation of America gets 26 MuirLab Patient Service Centers (PSCs) in Northern California Another hospital system is exiting the clinical laboratory outreach business. John Muir Health in Walnut Creek, California, agreed on Tuesday to sell its MuirLab business to Laboratory Corporation of America (NYSE: LH) in Burlington, North Carolina. In the deal, LabCorp will take over and operate 26 MuirLab Patient Service Centers (PSCs) in parts of Northern California, including Contra...

Bio-Reference Laboratories Acquires Hunter Laboratories as a Way to Enter California’s Competitive Clinical Laboratory Marketplace

Acquisition gives BRLI a core laboratory facility in Northern California, along with Hunter Laboratories’ Medi-Cal license, 29 patient service centers, and its courier network Yesterday’s announcement that BioReference Laboratories, Inc. (Nasdaq:BRLI), of Elmwood Park, New Jersey, had acquired a majority interest in Hunter Laboratories—a clinical laboratory company in Campbell, California—caught many medical laboratory executives by surprise. It is a strategic move that gives Bio-Reference...

Volume of Clinical Pathology Laboratory Specimens Increases at Bio-Reference and Sonic Healthcare

Meanwhile, both Quest Diagnostics and LabCorp report second quarter declines in specimen volume Fewer patients visiting physician offices during second quarter 2010 is considered to be one reason why specimen volume declined at clinical pathology laboratory testing giants Quest Diagnostics Incorporated (NYSE: DGX) and Laboratory Corporation of America (NYSE: LH) during that three-month period. For second quarter, LabCorp reported a 2% decline in specimen volume, along with a 4.2% increase in...

Why Some Clinical Laboratories Prosper During Tough Economic Times

Last week in New Orleans, the 14th Annual Executive War College on Laboratory and Pathology Management took place, with more than 450 senior laboratory administrators and pathologists in attendance from 11 nations across the globe. It was an upbeat gathering, despite the economic downturn being felt by hospitals, health systems, and laboratories in many countries. Some of that optimism stems from the fact that many laboratories continue to do well-clinically and financially. That was the case...
;